journal article·2023-04Open access

Phosphomevalonate Kinase Controls β‐Catenin Signaling via the Metabolite 5‐Diphosphomevalonate

Zhiqiang Chen, Xinyi Zhou, Xiaojun Zhou, Yi Tang, Mingzhu Lu, Jianhong Zhao, Chenhui Tian, Mingzhi Wu, Yanliang Liu, Edward V. Prochownik, Fubing Wang, Youjun Li

Advanced Science· Volume 10· Issue 12

Abstract

Abstract β‐catenin signaling is abnormally activated in cancer. Here, this work screens the mevalonate metabolic pathway enzyme PMVK to stabilize β‐catenin signaling using a human genome‐wide library. On the one hand, PMVK‐produced MVA‐5PP competitively binds to CKIα to prevent β‐catenin Ser45 phosphorylation and degradation. On the other hand, PMVK functions as a protein kinase to directly phosphorylate β‐catenin Ser184 to increase its protein nuclear localization. This synergistic effect of PMVK and MVA‐5PP together promotes β‐catenin signaling. In addition, PMVK deletion impairs mouse embryonic development and causes embryonic lethal. PMVK deficiency in liver tissue alleviates DEN/CCl4‐induced hepatocarcinogenesis. Finally, the small molecule inhibitor of PMVK, PMVKi5, is developed and PMVKi5 inhibits carcinogenesis of liver and colorectal tissues. These findings reveal a non‐canonical function of a key metabolic enzyme PMVK and a novel link between the mevalonate pathway and β‐catenin signaling in carcinogenesis providing a new target for clinical cancer therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Ubiquitin and proteasome pathways · RNA Research and Splicing · Plant biochemistry and biosynthesis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Hubei Key Laboratory of Cell Homeostasis College of Life Sciences Frontier Science Center for Immunology and Metabolism TaiKang Center for Life and Medical Sciences Wuhan University Wuhan 430072 P. R. China

Medical Research Institute Zhongnan Hospital of Wuhan University Wuhan University Wuhan 430071 P. R. China

Department of Gastrointestinal Surgery Renmin Hospital of Wuhan University Wuhan 430060 P. R. China

Division of Hematology/Oncology Children's Hospital of Pittsburgh of UPMC Department of Microbiology and Molecular Genetics Pittsburgh Liver Research Center and Hillman Cancer Center of UPMC University of Pittsburgh Medical Center Pittsburgh PA 15224 USA

Department of Laboratory Medicine and Center for Single‐Cell Omics and Tumor Liquid Biopsy Zhongnan Hospital of Wuhan University Wuhan 430071 P. R. China

Wuhan Research Center for Infectious Diseases and Cancer Chinese Academy of Medical Sciences Wuhan 430071 P. R. China

Funding

Fundamental Research Funds for the Central Universities

References (49)

Show source-provided references
1. 10.3322/caac.2166010.3322/caac.21660 ↗
2. 10.1056/NEJMra171326310.1056/NEJMra1713263 ↗
3. 10.1038/s41575-019-0217-810.1038/s41575-019-0217-8 ↗
4. 10.1007/s11427-019-1563-310.1007/s11427-019-1563-3 ↗
5. 10.1016/j.cell.2012.02.03210.1016/j.cell.2012.02.032 ↗
6. 10.1016/j.ccell.2017.11.01110.1016/j.ccell.2017.11.011 ↗
7. 10.1038/s41580-019-0190-710.1038/s41580-019-0190-7 ↗
8. 10.1016/j.canlet.2014.01.01310.1016/j.canlet.2014.01.013 ↗
9. 10.1038/nrc.2016.7610.1038/nrc.2016.76 ↗
10. 10.1038/ncb342710.1038/ncb3427 ↗
11. 10.1038/nrd222110.1038/nrd2221 ↗
12. 10.1073/pnas.091025810710.1073/pnas.0910258107 ↗
13. 10.1016/j.cell.2011.12.01710.1016/j.cell.2011.12.017 ↗
14. 10.1038/s41575-018-0075-910.1038/s41575-018-0075-9 ↗
15. 10.1053/j.gastro.2015.02.05610.1053/j.gastro.2015.02.056 ↗
16. 10.1038/s41467-019-09780-z10.1038/s41467-019-09780-z ↗
17. 10.1074/jbc.RA119.00997910.1074/jbc.RA119.009979 ↗
18. 10.1038/nrc341910.1038/nrc3419 ↗
19. 10.1038/s41556-018-0219-810.1038/s41556-018-0219-8 ↗
20. 10.1093/nar/gkw112110.1093/nar/gkw1121 ↗
21. 10.1016/j.cmet.2019.01.00210.1016/j.cmet.2019.01.002 ↗
22. 10.1136/gutjnl-2017-31544810.1136/gutjnl-2017-315448 ↗
23. 10.1053/j.gastro.2020.09.00910.1053/j.gastro.2020.09.009 ↗
24. 10.1126/science.124700510.1126/science.1247005 ↗
25. 10.1038/nature0835610.1038/nature08356 ↗
26. 10.1016/j.cell.2014.06.01310.1016/j.cell.2014.06.013 ↗
27. 10.1016/S0092-8674(02)00685-210.1016/S0092-8674(02)00685-2 ↗
28. 10.1101/cshperspect.a00789810.1101/cshperspect.a007898 ↗
29. 10.1021/bi052231u10.1021/bi052231u ↗
30. 10.1016/j.abb.2008.08.02410.1016/j.abb.2008.08.024 ↗
31. 10.1016/j.cca.2019.09.02210.1016/j.cca.2019.09.022 ↗
32. 10.1038/s41598-019-43947-410.1038/s41598-019-43947-4 ↗
33. 10.1016/j.jmb.2010.11.01010.1016/j.jmb.2010.11.010 ↗
34. 10.1016/j.tibs.2018.06.00310.1016/j.tibs.2018.06.003 ↗
35. 10.1016/j.cell.2011.02.01310.1016/j.cell.2011.02.013 ↗
36. 10.1016/j.clinbiochem.2007.03.01610.1016/j.clinbiochem.2007.03.016 ↗
37. 10.1136/gutjnl-2018-31758110.1136/gutjnl-2018-317581 ↗
38. 10.1016/j.semcancer.2004.04.00410.1016/j.semcancer.2004.04.004 ↗
39. 10.1038/ncb293610.1038/ncb2936 ↗
40. 10.1038/ncomms539310.1038/ncomms5393 ↗
41. 10.1016/0020-711X(84)90200-310.1016/0020-711X(84)90200-3 ↗
42. 10.1152/ajpgi.00359.200610.1152/ajpgi.00359.2006 ↗
43. 10.1053/j.gastro.2003.12.04710.1053/j.gastro.2003.12.047 ↗
44. 10.1158/0008-5472.CAN-18-034010.1158/0008-5472.CAN-18-0340 ↗
45. 10.1038/nmeth.304710.1038/nmeth.3047 ↗
46. 10.1016/j.molcel.2019.10.01510.1016/j.molcel.2019.10.015 ↗
47. 10.1007/s10822-013-9644-810.1007/s10822-013-9644-8 ↗
48. 10.1002/jcc.2125610.1002/jcc.21256 ↗
49. 10.1002/jcc.2133410.1002/jcc.21334 ↗